Concepedia

Publication | Open Access

CXCR2 inhibition enables NASH-HCC immunotherapy

DOIFull Paper Access

210

Citations

44

References

2022

Year

Jack Leslie, John B. G. Mackey, Thomas Jamieson, Erik Ramon‐Gil, Thomas M. Drake, Frédéric Fercoq, William Clark, Kathryn Gilroy, Ann Hedley, Colin Nixon,
Gut

Abstract

CXCR2-inhibition induces reprogramming of the tumour immune microenvironment that promotes ICI in NASH-HCC.

References

YearCitations

Page 1